Stock-Based Compensation Expense - Additional Information (Details) - RSU |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
$ / shares
shares
| |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| RSUs granted | 62,350 |
| Weighted Average Grant Date Fair Value Per Share, Granted | $ / shares | $ 79.37 |
| Number of shares vested | 36,900 |
| Share Based Compensation Award Tranche Four | |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| Number of RSUs outstanding | 38,920 |
| Probable of Achievement | |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| RSUs granted | 0 |
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|